PFBT
AQST icon

Parkside Financial Bank & Trust’s Aquestive Therapeutics AQST Stock Holding History

Parkside Financial Bank & Trust’s Portfolio AQST Stock Details AQST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-185
Closed -$536 – 2749
2025
Q1 		$536 Buy
+185
New +$560 ﹤0.01% 2343

Other funds holding AQST

BCM
Bratton Capital Management Fort Worth, Texas $40.7M AUM 43.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PFCS
Pale Fire Capital SE Prague, Czech Republic $1.14B AUM 42.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Parkside Financial Bank & Trust's AQST Position: Q2 2025 in Review

Parkside Financial Bank & Trust sold out of Aquestive Therapeutics (AQST) in Q2 2025, closing a stake of 185 shares — an estimated $536 sold.

Parkside Financial Bank & Trust first reported a position in AQST in Q1 2025 and held it in 1 quarter. The position peaked at $536 in Q1 2025. 116 funds tracked by Wall St. Rank hold AQST as of Q2 2025.

  • Parkside Financial Bank & Trust reported no remaining Aquestive Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Parkside Financial Bank & Trust sold 185 Aquestive Therapeutics shares in Q2 2025, an estimated $536.
  • Parkside Financial Bank & Trust first reported a position in Aquestive Therapeutics in Q1 2025 and held it in 1 quarter.
  • Parkside Financial Bank & Trust's Aquestive Therapeutics position peaked at $536 in Q1 2025.
  • 116 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q2 2025.

Based on Parkside Financial Bank & Trust's 13F filing for Q2 2025, filed 7 Aug 2025.